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grades ($272), however, the differences in expenditures were not
statistically signiﬁcant. No statistically signiﬁcant differences
were detected in the health care expenditures among categories
of other variables but this may be due partly to the relatively
small sample size. CONCLUSION: Gender and family size
appeared to play a role on the magnitude of health care expen-
ditures among dermatophytosis patients.
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OBJECTIVES: This study examined the relationship between
depressive symptoms and related medication adherence and
health care costs in older adults (age ≥ 65 years) with psoriasis.
METHODS: This was a prospective longitudinal cohort study
over a 2-year post enrollment period in a population of older
adults with psoriasis enrolled in a Medicare Health Maintenance
Organization (HMO) in southeastern United States with pre-
scription beneﬁts. Upon enrollment, each enrollee was mailed a
comprehensive health status assessment battery, which included
the Center for Epidemiologic Studies Depression (CES-D) scale.
Information on medication adherence (using medication posses-
sion ratio) and total health care utilization/costs following enroll-
ment were retrieved from the Medicare HMO database.
Sixty-three older adults with psoriasis using topical corticos-
teroids therapy and enrolled in the Medicare HMO for a 2 year
continuous period were included in the ﬁnal sample. RESULTS:
Nearly one-ﬁfths of the patient population had depressive symp-
toms. Patients with psoriasis who had depressive symptoms at
the time of enrollment were less likely to be adherent to topical
corticosteroid medication (Spearman rho = -0.29, p < 0.01) and
less likely to utilize health care resources as evidenced by lower
health care costs (Spearman rho = -0.27, p < 0.05), after con-
founder adjustment. CONCLUSIONS: The prevalence of
depressive symptoms in older adults with psoriasis is common-
place, with strong, yet unexplained correlations between pres-
ence of depressive symptoms and lower rates of medication and
health care service use among these patients.
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OBJECTIVES: To determine if the quality-of-life of AMD
patients with monocular visual dysfunction differs from that of
those with bilateral visual dysfunction. METHODS: A cross-
sectional study (n = 168) determined if there was a statistically
signiﬁcant difference in patient-reported health related quality-
of-life (HRQoL) of AMD patients with monocular versus 
bilateral visual dysfunction. Subjects underwent a series of 
interviewer-administered techniques to ascertain their HRQoL,
including the Visual Function Index (VF-14) and patient prefer-
ences elicited through both the time tradeoff (TTO) and stan-
dard reference gamble (SRG). Visual acuity obtained from a
subject’s better- and worse-seeing eye was categorized as 20/20
to 20/40, 20/40–20/70, 20/80–20/200, and worse than 20/200.
Based on the various combinations of these 4 visual acuity
groupings in the better-seeing (BSE) and worse-seeing eyes
(WSE), subjects were classiﬁed into one of 10 subgroups. Mul-
tivariate linear regression determined if an association existed
between various clinical variables and HRQoL. RESULTS: The
mean age was 72 years; 63% were females. Mean scores were:
VF-14, 66.1; TTO, 0.86; SRG, 0.89. Subjects with binocular
visual dysfunction reported a lower HRQoL compared to those
with monocular dysfunction (p < 0.001); mean differences in the
TTO, SRG, and VF-14 were 0.19 (SE = 0.04), 0.14 (SE = 0.04),
and 59.2 (SE = 3.9), respectively. Multivariate models demon-
strated that only visual acuity subgrouping, a function of acuity
in both the BSE and WSE, was associated with HRQoL score
(overall eta2 = 34.8%, p < 0.01, and partial eta2 equal to 22%
[TTO], 20% [SRG] and 60% [VF-14]). Models including both
BSE and WSE visual acuity explained an additional 10% in
HRQoL variability compared to models with only BSE visual
acuity. CONCLUSIONS: Subjects with binocular visual dys-
function reported a signiﬁcantly lower HRQoL as compared to
those with monocular dysfunction. These results suggest that
binocular vision is a better predictor of HRQoL in AMD than
only visual acuity in the BSE.
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OBJECTIVE: The lack of speciﬁc ICD-9 codes and under self-
reporting and diagnosis of ChHD suggests a need for a self-
assessment survey to identify ChHD. This pilot study was
conducted to validate a newly designed self-assessment ques-
tionnaire and the Skindex-29 QoL instrument for use by ChHD
patients. METHODS: A clinical questionnaire, consisting of 16
questions, was developed to identify patients with ChHD and to
assess its severity, through patient self-administration. Sensitiv-
ity, speciﬁcity, and receiver operating characteristic (ROC) curve
were used to evaluate how closely the ChHD diagnosis based on
self-assessment concurred with physician’s diagnoses. Also,
Skindex-29, a QoL instrument with 29 questions not previously
validated in a ChHD population, was evaluated for internal con-
sistency and construct validity for ChHD patients in this study.
Forty-patients (ChHD n = 20; other skin disorders n = 20), with
a mean age of 46.6 ± 14.8 years and 30% males, were randomly
selected from a dermatology clinic in Louisville, Kentucky for
this pilot study. RESULTS: The performance of the clinical ques-
tionnaire matched the physicians’ diagnosis in identifying ChHD
with a sensitivity of 85%, a speciﬁcity of 95%, and an area under
the ROC curve of 0.83. The internal consistency of the Skindex-
29 was higher than that reported previously in a general der-
matology population, with a Cronbach alpha of 0.77 to 0.94 for
3 different (symptoms, emotions and functioning) domains. The
construct validity of Skindex-29 was evaluated by examining the
correlation between the overall score and physician’s assessment
of ChHD severity. The Pearson rho was 0.55 (p = 0.07), slightly
lower than that reported previously, but higher than that
reported for other QoL instruments. CONCLUSIONS: This
study indicates that the newly developed ChHD self-assessment
